(Q51786253)

English

Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711).

scientific article published on 13 September 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Melpomeni Peppa

1

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

Harold Brem

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

Weijing Cai

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

Jiang-Gang Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

John Basgen

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

Zhu Li

6

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

Helen Vlassara

7

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

Jaime Uribarri

8

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

publication date

13 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

American Journal of Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

26

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

430-436

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

Advanced glycoxidation. A new risk factor for cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

Role of advanced glycation end products in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

Therapeutic potential of breakers of advanced glycation end product–protein crosslinks

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

Role of megalin in endocytosis of advanced glycation end products: implications for a novel protein binding to both megalin and advanced glycation end products.

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

Chelating activity of advanced glycation end-product inhibitors

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction

1 reference

https://api.crossref.org/works/10.1159%2F000095786

21 January 2018

Identifiers

10.1159/000095786

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/16974073

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51786253&oldid=1516220925"